Document is current
Any future updates will be listed below
-
Authors
O’Leary, Meghan C. http://orcid.org/0000-0001-6954-7141
Lich, Kristen Hassmiller
Gu, Yifan
Wheeler, Stephanie B.
Coronado, Gloria D.
Bartelmann, Sarah E.
Lind, Bonnie K.
Mayorga, Maria E.
Davis, Melinda M.
-
Funding
Funding for this research was provided by:
Centers for Disease Control and Prevention (U48-DP005017, U48-DP005006)
Agency for Healthcare Research and Quality (K12 HS022981 01, 1K07CA211971-01A1)
National Cancer Institute (UH2AT007782)
National Cancer Institute (UH3CA188640)
- License Information
-
More Information
Article History
Received: 14 February 2019
Accepted: 22 April 2019
First Online: 9 May 2019
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board at the Oregon Health & Science University, the site where all analyses for this study were conducted, with a waiver of informed consent (IRB #8865).
: Not applicable.
: From November 2014 – August 2015, Gloria Coronado served as a co-Investigator on an industry-funded study, funded by EpiGenomics, to evaluate patient adherence to an experimental blood test for colorectal cancer. From September 2017 – June 2018, Gloria Coronado served as the Principal Investigator on an industry-funded study, funded by Quidel Corporation, to compare the clinical performance of an experimental FIT to an FDA-approved FIT. Stephanie Wheeler receives unrelated grant funding to her institution from Pfizer. All other authors report no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
